UPDATE : Friday, January 19, 2018
상단여백
Which certificates do you need for 4th industrial revolution? by Nam Doo-hyun 2018-01-18 12:18
Shares of ‘Celltrion trio’ plummet on profit-taking by Nam Doo-hyun 2018-01-18 11:10
‘Risk-sharing agreements improved access to expensive drugs’ by Nam Doo-hyun 2018-01-17 16:15
Korea’s pharmaceutical exports up 20% in 2017 by Nam Doo-hyun 2018-01-16 11:21
Shares of eye drops/masks makers rise on fine dust measure by Nam Doo-hyun 2018-01-15 15:48
라인
'Postmenopausal use of aromatase inhibitor ups fracture risk’ by Nam Doo-hyun 2018-01-15 14:42
Gaucher disease drug effective for retention, early treatment, Sanofi says by Nam Doo-hyun 2018-01-15 10:27
Luxturna to open gene therapies market: analyst by Nam Doo-hyun 2018-01-10 15:48
Test for fetal sex chromosome defects wins patent by Nam Doo-hyun 2018-01-10 14:39
Antibodies drug suggested against N. Korean anthrax threat by Nam Doo-hyun 2018-01-05 12:03
라인
Venture capital investment in biomedical sector drops 20% in 2017 by Nam Doo-hyun 2018-01-04 09:30
70% of biotech firms enjoy stock price gains in 2017 by Nam Doo-hyun 2018-01-02 17:42
Kolon Life Science’s shares plummet on drifting export deal by Nam Doo-hyun 2017-12-21 13:16
₩500-billion Invossa technology export to Japan in peril by Nam Doo-hyun 2017-12-20 14:59
Will Takeda, Dong-A ST benefit from new hypertension guideline? by Nam Doo-hyun 2017-12-19 16:15
라인
Boehringer Ingelheim Korea’s labor union protests early retirement program by Nam Doo-hyun 2017-12-19 14:35
‘Celltrion’s annual revenue to top ₩3 trillion in 5 years’ by Nam Doo-hyun 2017-12-18 15:55
Yuhan’s chemo combo YH24931 more effective than immunotherapy alone by Nam Doo-hyun 2017-12-18 11:51
‘Postmenopausal women in 50s shouldn’t take phytoestrogen’ by Nam Doo-hyun 2017-12-18 10:49
‘Surge of gene-therapy providing hospitals to benefit Invossa’ by Nam Doo-hyun 2017-12-12 15:59
여백
여백
여백
Back to Top